Search

Your search keyword '"Mitrani, Raul"' showing total 481 results
Start Over Author "Mitrani, Raul"
481 results on '"Mitrani, Raul"'

3. A Phase II study of autologous mesenchymal stromal cells and c‐kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT‐HF trial

Author

Bolli, Roberto, Mitrani, Raul D, Hare, Joshua M, Pepine, Carl J, Perin, Emerson C, Willerson, James T, Traverse, Jay H, Henry, Timothy D, Yang, Phillip C, Murphy, Michael P, March, Keith L, Schulman, Ivonne H, Ikram, Sohail, Lee, David P, O'Brien, Connor, Lima, Joao A, Ostovaneh, Mohammad R, Ambale‐Venkatesh, Bharath, Lewis, Gregory, Khan, Aisha, Bacallao, Ketty, Valasaki, Krystalenia, Longsomboon, Bangon, Gee, Adrian P, Richman, Sara, Taylor, Doris A, Lai, Dejian, Sayre, Shelly L, Bettencourt, Judy, Vojvodic, Rachel W, Cohen, Michelle L, Simpson, Lara, Aguilar, David, Loghin, Catalin, Moyé, Lem, Ebert, Ray F, Davis, Barry R, Simari, Robert D, and Network, for the Cardiovascular Cell Therapy Research

Subjects
Biomedical and Clinical Sciences, Cardiovascular Medicine and Haematology, Cardiovascular, Clinical Trials and Supportive Activities, Rehabilitation, Stem Cell Research, Clinical Research, Stem Cell Research - Nonembryonic - Human, Heart Disease, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, Heart Failure, Humans, Mesenchymal Stem Cell Transplantation, Mesenchymal Stem Cells, Minnesota, Quality of Life, Stroke Volume, Treatment Outcome, Ventricular Function, Left, Cell-based therapy, Clinical trial, Heart failure, Cardiovascular Cell Therapy Research Network, Cardiorespiratory Medicine and Haematology, Cardiovascular System & Hematology, Cardiovascular medicine and haematology
Abstract

AimsCONCERT-HF is an NHLBI-sponsored, double-blind, placebo-controlled, Phase II trial designed to determine whether treatment with autologous bone marrow-derived mesenchymal stromal cells (MSCs) and c-kit positive cardiac cells (CPCs), given alone or in combination, is feasible, safe, and beneficial in patients with heart failure (HF) caused by ischaemic cardiomyopathy.Methods and resultsPatients were randomized (1:1:1:1) to transendocardial injection of MSCs combined with CPCs, MSCs alone, CPCs alone, or placebo, and followed for 12 months. Seven centres enrolled 125 participants with left ventricular ejection fraction of 28.6 ± 6.1% and scar size 19.4 ± 5.8%, in New York Heart Association class II or III. The proportion of major adverse cardiac events (MACE) was significantly decreased by CPCs alone (-22% vs. placebo, P = 0.043). Quality of life (Minnesota Living with Heart Failure Questionnaire score) was significantly improved by MSCs alone (P = 0.050) and MSCs + CPCs (P = 0.023) vs. placebo. Left ventricular ejection fraction, left ventricular volumes, scar size, 6-min walking distance, and peak oxygen consumption did not differ significantly among groups.ConclusionsThis is the first multicentre trial assessing CPCs and a combination of two cell types from different tissues in HF patients. The results show that treatment is safe and feasible. Even with maximal guideline-directed therapy, both CPCs and MSCs were associated with improved clinical outcomes (MACE and quality of life, respectively) in ischaemic HF without affecting left ventricular function or structure, suggesting possible systemic or paracrine cellular mechanisms. Combining MSCs with CPCs was associated with improvement in both these outcomes. These results suggest potential important beneficial effects of CPCs and MSCs and support further investigation in HF patients.

Published
2021

4. Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients The CCTRN SENECA Trial

Author

Bolli, Roberto, Perin, Emerson C, Willerson, James T, Yang, Phillip C, Traverse, Jay H, Henry, Timothy D, Pepine, Carl J, Mitrani, Raul D, Hare, Joshua M, Murphy, Michael P, March, Keith L, Ikram, Sohail, Lee, David P, O’Brien, Connor, Durand, Jean-Bernard, Miller, Kathy, Lima, Joao A, Ostovaneh, Mohammad R, Ambale-Venkatesh, Bharath, Gee, Adrian P, Richman, Sara, Taylor, Doris A, Sayre, Shelly L, Bettencourt, Judy, Vojvodic, Rachel W, Cohen, Michelle L, Simpson, Lara M, Lai, Dejian, Aguilar, David, Loghin, Catalin, Moyé, Lem, Ebert, Ray F, Davis, Barry R, Simari, Robert D, and Network, Cardiovascular Cell Therapy Research

Subjects
Biomedical and Clinical Sciences, Cardiovascular Medicine and Haematology, Oncology and Carcinogenesis, Cardiovascular, Clinical Research, Cancer, Heart Disease, Stem Cell Research, Clinical Trials and Supportive Activities, cardiac repair, cardiooncology, chemotherapy, heart failure, stem cells, Cardiovascular Cell Therapy Research Network, Cardiovascular medicine and haematology, Oncology and carcinogenesis
Abstract

BackgroundAnthracycline-induced cardiomyopathy (AIC) may be irreversible with a poor prognosis, disproportionately affecting women and young adults. Administration of allogeneic bone marrow-derived mesenchymal stromal cells (allo-MSCs) is a promising approach to heart failure (HF) treatment.ObjectivesSENECA (Stem Cell Injection in Cancer Survivors) was a phase 1 study of allo-MSCs in AIC.MethodsCancer survivors with chronic AIC (mean age 56.6 years; 68% women; NT-proBNP 1,426 pg/ml; 6 enrolled in an open-label, lead-in phase and 31 subjects randomized 1:1) received 1 × 108 allo-MSCs or vehicle transendocardially. Primary objectives were safety and feasibility. Secondary efficacy measures included cardiac function and structure measured by cardiac magnetic resonance imaging (CMR), functional capacity, quality of life (Minnesota Living with Heart Failure Questionnaire), and biomarkers.ResultsA total of 97% of subjects underwent successful study product injections; all allo-MSC-assigned subjects received the target dose of cells. Follow-up visits were well-attended (92%) with successful collection of endpoints in 94% at the 1-year visit. Although 58% of subjects had non-CMR compatible devices, CMR endpoints were successfully collected in 84% of subjects imaged at 1 year. No new tumors were reported. There were no significant differences between allo-MSC and vehicle groups with regard to clinical outcomes. Secondary measures included 6-min walk test (p = 0.056) and Minnesota Living with Heart Failure Questionnaire score (p = 0.048), which tended to favor the allo-MSC group.ConclusionsIn this first-in-human study of cell therapy in patients with AIC, transendocardial administration of allo-MSCs appears safe and feasible, and CMR was successfully performed in the majority of the HF patients with devices. This study lays the groundwork for phase 2 trials aimed at assessing efficacy of cell therapy in patients with AIC.

Published
2020

18. Mechanistic Insights From Trials of Atrial Fibrillation Ablation: Charting a Course for the Future.

Author

Goldberger, Jeffrey J., Mitrani, Raul D., Zaatari, Ghaith, and Narayan, Sanjiv M.

Abstract

Success rates for catheter ablation of atrial fibrillation (AF), particularly persistent AF, remain suboptimal. Pulmonary vein isolation has been the cornerstone for catheter ablation of AF for over a decade. While successful for most patients, pulmonary vein isolation alone is still insufficient for a substantial minority. Frustratingly, multiple clinical trials testing a diverse array of additional ablation approaches have led to mixed results, with no current strategy that improves AF outcomes beyond pulmonary vein isolation in all patients. Nevertheless, this large collection of data could be used to extract important insights regarding AF mechanisms and the diversity of the AF syndrome. Mechanistically, the general model for arrhythmogenesis prompts the need for tools to individually assess triggers, drivers, and substrates in individual patients. A key goal is to identify those who will not respond to pulmonary vein isolation, with novel approaches to phenotyping that may include mapping to identify alternative drivers or critical substrates. This, in turn, can allow for the implementation of phenotype-based, targeted approaches that may categorize patients into groups who would or would not be likely to respond to catheter ablation, pharmacological therapy, and risk factor modification programs. One major goal is to predict individuals in whom additional empirical ablation, while feasible, may be futile or lead to atrial scarring or proarrhythmia. This work attempts to integrate key lessons from successful and failed trials of catheter ablation, as well as models of AF, to suggest future paradigms for AF treatment. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

24. Comparison of electrogram characteristics in persistent atrial fibrillation.

Author

Goldberger, Jeffrey J., Zaatari, Ghaith, Mitrani, Raul D., Blandon, Catherine, Bohorquez, Jorge, Ng, Jason, Ng, Justin, Velasquez, Alex, Lambrakos, Litsa, and Arora, Rishi

Subjects
ATRIAL fibrillation treatment, RESEARCH, MYOCARDIAL depressants, CATHETER ablation, COMPARATIVE studies, TREATMENT effectiveness, ELECTROCARDIOGRAPHY, DESCRIPTIVE statistics, RESEARCH funding, STATISTICAL correlation, LEFT heart atrium, RIGHT heart atrium
Abstract

Introduction: Multiple analysis techniques evaluate electrograms during atrial fibrillation (AF), but none have been established to guide catheter ablation. This study compares electrogram properties recorded from multiple right (RA) and left atrial (LA) sites. Methods: Multisite LA/RA mapping (281 ± 176/239 ± 166 sites/patient) was performed in 42 patients (30 males, age 63 ± 9 years) undergoing first (n = 32) or redo‐AF ablation (n = 10). All electrogram recordings were visually reviewed and artifactual signals were excluded leaving a total of 21 846 for analysis. Electrogram characteristics evaluated were cycle length (CL), amplitude, Shannon's entropy (ShEn), fractionation interval, dominant frequency, organizational index, and cycle length of most recurrent morphology (CLR) from morphology recurrence plot analysis. Results: Electrogram characteristics were correlated to each other. All pairwise comparisons were significant (p <.001) except for dominant frequency and CLR (p =.59), and amplitude and dominant frequency (p =.38). Only ShEn and fractionation interval demonstrated a strong negative correlation (r = −.94). All other pairwise comparisons were poor to moderately correlated. The relationships are highly conserved among patients, in the RA versus LA, and in those undergoing initial versus redo ablations. Antiarrhythmic drug therapy did not have a significant effect on electrogram characteristics, except minimum ShEn. Electrogram characteristics associated with ablation outcome were shorter minimum CLR, lower minimum ShEn, and longer mimimum CL. There was minimal overlap between the top 10 sites identified by one electrogram characteristic and the top 10 sites identified by the other 10 characteristics. Conclusion: Multiple techniques can be employed for electrogram analysis in AF. In this analysis of eight different electrogram characteristics, seven were poorly to moderately correlated and do not identify similar locations. Only some characteristics were predictive of ablation outcome. Further studies to consider electrogram properties, perhaps in combination, for categorizing and/or mapping AF are warranted. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

27. Abstract 14080: A Phase II Randomized, Double-blind, Controlled Trial of Combined Mesenchymal Stromal Cells and C-kit+ Cardiac Progenitor Cells in Ischemic Heart Failure: The CCTRN CONCERT-HF Trial

Author

Bolli, Roberto, Mitrani, Raul, Hare, Joshua M, Pepine, Carl J, Perin, Emerson C, Willerson, James T, TRAVERSE, Jay H, Henry, Timothy D, Yang, Phillip C, Murphy, Michael P, Lewis, Gregory, Ac Lima, Joao A, Khan, Aisha, Lai, Dejian, Ebert, Ray, Davis, Barry R, and Simari, Robert D

Published
2020
Full Text
View/download PDF

31. ATRIAL ECG DYNAMICS IN ATRIAL FIBRILLATION

Author

McDermott, Laura, primary, Bohorquez, Jorge, additional, Zaatari, Ghaith, additional, Mitrani, Raul D., additional, Velasquez, Alex H., additional, Lambrakos, Litsa Konstance, additional, and Goldberger, Jeffrey J., additional

Published
2023
Full Text
View/download PDF

32. Gender, Race, and Health Insurance Status in Patients Undergoing Catheter Ablation for Atrial Fibrillation

Author

Patel, Nileshkumar, Deshmukh, Abhishek, Thakkar, Badal, Coffey, James O., Agnihotri, Kanishk, Patel, Achint, Ainani, Nitesh, Nalluri, Nikhil, Patel, Nilay, Patel, Nish, Patel, Neil, Badheka, Apurva O., Kowalski, Marcin, Hendel, Robert, Viles-Gonzalez, Juan, Noseworthy, Peter A., Asirvatham, Samuel, Lo, Kaming, Myerburg, Robert J., and Mitrani, Raul D.

Published
2016
Full Text
View/download PDF

35. Contributors

Author

Aagaard, Philip, primary, Abrams, Dominic James, additional, Abriel, Hugues, additional, Adkisson, Wayne O., additional, Agullo-Pascual, Esperanza, additional, Alvarado, Francisco J., additional, Amin, Ahmad S., additional, Antzelevitch, Charles, additional, Anumonwo, Justus M.B., additional, Armaganijan, Luciana, additional, Arya, Arash, additional, Asirvatham, Samuel, additional, Atienza, Felipe, additional, Backx, Peter H., additional, Ballou, Lisa M., additional, Balse, Elise, additional, Balulad, Sujata, additional, Barbuti, Andrea, additional, Bardy, Gust H., additional, Bassil, Guillaume, additional, Benditt, David G., additional, Berenfeld, Omer, additional, Bers, Donald M., additional, Binah, Ofer, additional, Bogun, Frank, additional, Bongianino, Rossana, additional, Boyle, Noel G., additional, Boyle, Patrick M., additional, Breithardt, Günter, additional, Brini, Marisa, additional, Brink, Peter R., additional, Brugada, Pedro, additional, Buch, Eric, additional, Bukauskas, Feliksas F., additional, Calkins, Hugh, additional, Callans, David J., additional, Caples, Sean M., additional, Carafoli, Ernesto, additional, Catterall, William A., additional, Cerrone, Marina, additional, Chaumeil, Arnaud, additional, Chen, Caressa, additional, Chen, Lan S., additional, Chen, Peng-Sheng, additional, Cheng, Jianding, additional, Chiamvimonvat, Nipavan, additional, Christini, David J., additional, Chugh, Aman, additional, Climent, Andreu M., additional, Cohen, Ira S., additional, Connolly, Stuart J., additional, Cooper, Lebron, additional, Crespo, Eric M., additional, Crotti, Lia, additional, Csepe, Thomas A., additional, Cuoco, Frank, additional, Curtis, Anne B., additional, Damiano, Ralph J., additional, Darbar, Dawood, additional, Das, Mithilesh K., additional, d’Avila, Andre, additional, Delmar, Mario, additional, Delpón, Eva, additional, Denegri, Marco, additional, Denis, Arnaud, additional, Derval, Nicolas, additional, Deschênes, Isabelle, additional, Deshmukh, Abhishek, additional, Di Biase, Luigi, additional, Dickfeld, Timm M., additional, Dierckx, Hans, additional, Dinov, Borislav, additional, Dixit, Sanjay, additional, Dobrev, Dobromir, additional, Dubois, Remi, additional, Eckardt, Lars, additional, Edwards, Andrew G., additional, Ellenbogen, Kenneth A., additional, Ellinor, Patrick T., additional, Estes, N.A. Mark, additional, Fabritz, Larissa, additional, Fedorov, Vadim V., additional, Fernandez, Antonio B., additional, Teijeira Fernández, Elvis, additional, Filgueiras-Rama, David, additional, Fishbein, Michael C., additional, Fishman, Glenn I., additional, Frankel, David S., additional, Friedman, Paul, additional, Frontera, Antonio, additional, Gami, Apoor S., additional, Garabelli, Paul, additional, George, Alfred L., additional, Gerstenfeld, Edward P., additional, Gizurarson, Sigfus, additional, Gold, Michael R., additional, Goldberger, Jeffrey J., additional, Grace, Andrew, additional, Grassi, Guido, additional, Greenfield, Ruth Ann, additional, Gross, Wendy L., additional, Grubb, Blair P., additional, Guillem, María S., additional, Györke, Sándor, additional, Haïssaguerre, Michel, additional, Hake, Johan, additional, Halperin, Henry R., additional, Hansen, Brian J., additional, Hatem, Stéphane, additional, Hayes, David L., additional, Heijman, Jordi, additional, Herron, Todd J., additional, Hindricks, Gerhard, additional, Hocini, Mélèze, additional, Hohnloser, Stefan H., additional, Holmes, David R., additional, Hoshijima, Masahiko, additional, Hund, Thomas J., additional, Hutchinson, Mathew D., additional, Ilkhanoff, Leonard, additional, Ingles, Jodie, additional, Ip, James E., additional, Jackman, Warren M., additional, Jackson, Nicholas, additional, Jaïs, Pierre, additional, Jalife, José, additional, Jhun, Bong Sook, additional, John, Roy M., additional, Jongbloed, Monique, additional, Jordaens, Luc, additional, Kalman, Jonathan M., additional, Kamp, Timothy J., additional, Kanj, Mohamed H., additional, Kapa, Suraj, additional, Karabin, Beverly, additional, Karakikes, Ioannis, additional, Katritsis, Demosthenes G., additional, Kaur, Kuljeet, additional, Kirchhof, Paulus, additional, Kléber, André G., additional, Klein, George J., additional, Kohl, Peter, additional, Koneru, Jayanthi N., additional, Koruth, Jacob S., additional, Krahn, Andrew D., additional, Krogh-Madsen, Trine, additional, Kuck, Karl Heinz, additional, Kumar, Saurabh, additional, Kushnir, Alexander, additional, Lakdawala, Neal K., additional, Laksman, Zachary W.M., additional, Latchamsetty, Rakesh, additional, Lau, Dennis H., additional, Lerman, Bruce B., additional, Lin, Richard Z., additional, Lin, Shien-Fong, additional, Link, Mark S., additional, Liu, Bin, additional, Liu, Christopher F., additional, Lockwood, Deborah J., additional, Lopatin, Anatoli N., additional, Lubitz, Steven A., additional, Mahajan, Rajiv, additional, Makielski, Jonathan C., additional, Malik, Marek, additional, Marchlinski, Francis E., additional, Markowitz, Steven M., additional, Maron, Barry J., additional, Maron, Martin S., additional, Marx, Steven O., additional, Massé, Stéphane, additional, McCulloch, Andrew D., additional, McKelvie-Sebileau, Pippa, additional, Melby, Spencer J., additional, Metzner, Andreas, additional, Michailova, Anushka P., additional, Michaud, Gregory F., additional, Miller, John M., additional, Mishra, Jyotsna, additional, Mitrani, Raul D., additional, Mohler, Peter J., additional, Morady, Fred, additional, Myerburg, Robert J., additional, Nakagawa, Hiroshi, additional, Nalliah, Chrishan Joseph, additional, Nanthakumar, Kumaraswamy, additional, Napolitano, Carlo, additional, Narayan, Sanjiv M., additional, Natale, Andrea, additional, Nattel, Stanley, additional, Nazarian, Saman, additional, Nguyen, Thao P., additional, Nogami, Akihiko, additional, Noujaim, Sami F., additional, Nubret Le Coniat, Karine, additional, Olshansky, Brian, additional, O-Uchi, Jin, additional, Oudit, Gavin Y., additional, Ouyang, Feifan, additional, Ozcan, Cevher, additional, Packer, Douglas L., additional, Pandit, Sandeep V., additional, Panfilov, Alexander V., additional, Park, David S., additional, Patocskai, Bence, additional, Pauza, Dainius H., additional, Pauziene, Neringa, additional, Piccini, Jonathan P., additional, Pitt, Geoffrey S., additional, Po, Sunny S., additional, Prasad, Abhiram, additional, Priori, Silvia G., additional, Radwański, Przemysław B., additional, Rappel, Wouter-Jan, additional, Reiser, Michelle, additional, Restrepo, Alejandro Jimenez, additional, Robinson, Richard B., additional, Roden, Dan M., additional, Rosen, Michael R., additional, Rosso, Raphael, additional, Rudy, Yoram, additional, Rysevaite-Kyguoliene, Kristina, additional, Sabbah, Hani N., additional, Sacher, Frederic, additional, Sachse, Frank B., additional, Saguner, Ardan M., additional, Sanders, Prashanthan, additional, Sanguinetti, Michael C., additional, Santangeli, Pasquale, additional, Sarraf, Mohammad, additional, Satin, Jonathan, additional, Schalij, Martin Jan, additional, Scherlag, Benjamin J., additional, Schill, Matthew R., additional, Schleifer, J. William, additional, Schuessler, Richard B., additional, Schwartz, Peter J., additional, Seeger, Timon, additional, Semsarian, Christopher, additional, Seravalle, Gino, additional, Shah, Ashok J., additional, Shaw, Robin M., additional, Shen, Mark J., additional, Shen, Win–Kuang, additional, Sheu, Shey-Shing, additional, Shivkumar, Kalyanam, additional, Silva, Jennifer N.A., additional, Skanes, Allan C., additional, Soejima, Kyoko, additional, Somers, Virend K., additional, Sorajja, Dan, additional, Stavrakis, Stavros, additional, Steinberg, Christian, additional, Stevenson, Lynne Warner, additional, Stevenson, William G., additional, Sweeney, Michael O., additional, Swerdlow, Charles, additional, Takigawa, Masateru, additional, Tamargo, Juan, additional, Tandri, Harikrishna, additional, Tedrow, Usha B., additional, Thompson, Nathaniel, additional, Thompson, Paul D., additional, Tomaselli, Gordon F., additional, Towbin, Jeffrey A., additional, Trayanova, Natalia A., additional, Tristani-Firouzi, Martin, additional, Tseng, Zian H., additional, Ueda, Akiko, additional, Valdivia, Héctor H., additional, Valiunas, Virginijus, additional, van der Werf, Christian, additional, Van Hare, George F., additional, Vidmar, David, additional, Viskin, Sami, additional, Voigt, Niels, additional, Walsh, Edward P., additional, Wang, Paul J., additional, Wehrens, Xander H.T., additional, Weiss, Mark S., additional, Wilde, Arthur A.M., additional, Wilkoff, Bruce L., additional, Woo, Y. Joseph, additional, Wu, Joseph C., additional, Yee, Raymond, additional, Zaman, Junaid A.B., additional, Zarzoso, Manuel, additional, Zeitler, Emily P., additional, Zeppenfeld, Katja, additional, Zghaib, Tarek, additional, Zhang, Xiao-Dong, additional, and Zipes, Douglas P., additional

Published
2018
Full Text
View/download PDF

40. Influence of left ventricular remodeling on atrial fibrillation recurrence and cardiovascular hospitalizations in patients undergoing rhythm-control therapy

Author

Shah, Neeraj, Badheka, Apurva O., Grover, Peeyush M., Patel, Nileshkumar J., Chothani, Ankit, Mehta, Kathan, Hoosien, Michael, Singh, Vikas, Savani, Ghanshyambhai T., Deshmukh, Abhishek, Rathod, Ankit, Patel, Nilay, Panaich, Sidakpal S., Arora, Shilpkumar, Schwartz, Charles, Blisker, Martin, Coffey, James O., Mitrani, Raul D., Fuster, Valentin, and Viles-Gonzalez, Juan F.

Published
2014
Full Text
View/download PDF

41. Outcomes in Atrial Fibrillation Patients With and Without Left Ventricular Hypertrophy When Treated With a Lenient Rate-Control or Rhythm-Control Strategy

Author

Badheka, Apurva O., Shah, Neeraj, Grover, Peeyush M., Patel, Nileshkumar J., Chothani, Ankit, Mehta, Kathan, Singh, Vikas, Deshmukh, Abhishek, Savani, Ghanshyambhai T., Rathod, Ankit, Panaich, Sidakpal S., Patel, Nilay, Arora, Shilpkumar, Bhalara, Vipulkumar, Coffey, James O., Mitrani, Raul D., Halperin, Jonathan L., and Viles-Gonzalez, Juan F.

Published
2014
Full Text
View/download PDF

42. Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit+ Cardiac Stem Cells As Regenerative Therapy for Heart Failure)

Author

Bolli, Roberto, Hare, Joshua M., March, Keith L., Pepine, Carl J., Willerson, James T., Perin, Emerson C., Yang, Phillip C., Henry, Timothy D., Traverse, Jay H., Mitrani, Raul D., Khan, Aisha, Hernandez-Schulman, Ivonne, Taylor, Doris A., DiFede, Darcy L., Lima, João A.C., Chugh, Atul, Loughran, John, Vojvodic, Rachel W., Sayre, Shelly L., Bettencourt, Judy, Cohen, Michelle, Moyé, Lem, Ebert, Ray F., and Simari, Robert D.

Published
2018
Full Text
View/download PDF

44. Cardiac Troponin Testing as a Component of Return to Play Cardiac Screening in Young Competitive Athletes Following SARS‐CoV‐2 Infection

Author

Moulson, Nathaniel, primary, Petek, Bradley J., additional, Churchill, Timothy W., additional, Drezner, Jonathan A., additional, Harmon, Kimberly G., additional, Kliethermes, Stephanie A., additional, Mellacheruvu, Pranav, additional, Patel, Manesh R., additional, Baggish, Aaron L., additional, Asif, Irfan M., additional, Borchers, James, additional, Edenfield, Katherine M., additional, Emery, Michael S., additional, Goerl, Kyle, additional, Hainline, Brian, additional, Jone, Pei‐Ni, additional, Kim, Jonathan H., additional, Kliethermes, Stephanie, additional, Kraus, William E., additional, Lampert, Rachel, additional, Leiszler, Matthew, additional, Levine, Benjamin D., additional, Martinez, Matthew W., additional, Moulson, Nathaniel, additional, O'Connor, Francis G., additional, Phelan, Dermot, additional, Rink, Lawrence D., additional, Taylor, Herman A., additional, Ade, Carl, additional, Aiyer, Aryan, additional, Alfadhli, Jarrah, additional, Amaradio, Chloe, additional, Anderson, Scott, additional, Arlis‐Mayor, Stephanie, additional, Aubry, Jonathan S., additional, Austin, Andrea, additional, Balcik, Brenden J., additional, Beaver, Timothy, additional, Benitez, Nicolas, additional, Berkstresser, Brant, additional, Best, Thomas M., additional, Bohon, Tiffany, additional, Bonnet, Jonathan P., additional, Boyington, Elizabeth, additional, Bray, James, additional, Bryant, Jenna, additional, Bytomski, Jeffrey, additional, Carnahan, Sean, additional, Chamberlain, Rachel, additional, Charters, Samantha, additional, Chill, Nicholas, additional, Clark, Daniel E., additional, Comeau, Douglas, additional, Cook, Laura E., additional, Corey, Deanna, additional, Costa, Amy, additional, Crowther, Marshall, additional, Dalia, Tarun, additional, Davidson, Craig, additional, Davitt, Kaitlin, additional, De St. Maurice, Annabelle, additional, Dean, Peter N., additional, Dendy, Jeffrey M., additional, DeZenzo, Katelyn, additional, Dimitris, Courtney, additional, Doperak, Jeanne, additional, Duffaut, Calvin, additional, Fafara, Craig, additional, Fahy, Katherine, additional, Ferderber, Jason, additional, Finn, Megan, additional, Fish, Frank A., additional, Fitch, R. Warne, additional, Galante, Angelo, additional, Gerlt, Todd, additional, Gest, Amy, additional, Gilson, Carla, additional, Goldberger, Jeffrey, additional, Goldman, Joshua, additional, Groezinger, Erich, additional, Guin, Jonathan R., additional, Halseth, Heather, additional, Hare, Joshua, additional, Harness, Beth, additional, Hatamiya, Nicolas, additional, Haylett, Julie, additional, Hazen, Neal, additional, Hughes, Sean G., additional, Hiroi, Yeun, additional, Hockenbrock, Amy, additional, Honsvall, Amanda, additional, Hopp, Jennifer, additional, Howard, Julia, additional, Huba, Samantha, additional, Husaini, Mustafa, additional, Huston, Lindsay, additional, Hwang, Calvin, additional, Irvin, Laura, additional, Iven, Val Gene, additional, Jones, Robert, additional, Joyce, Donald, additional, Karlson, Kristine, additional, Kent, Jeremy, additional, Klein, Christian F., additional, Klenck, Chris, additional, Kirk, Michele, additional, Knight, Jordan, additional, Knippa, Laura, additional, Knutson, Madeleine, additional, Kovacs, Louis E., additional, Kuscher, Yumi, additional, Kussman, Andrea, additional, Landreth, Chrissy, additional, Leu, Amy, additional, Lothian, Dylan, additional, Lowery, Maureen, additional, Lukjanczuk, Andrew, additional, MacKnight, John M., additional, Magee, Lawrence M., additional, Magnuson, Marja‐Liisa, additional, Mares, Aaron V., additional, Marquez, Anne, additional, McKinley, Grant, additional, Meester, Scott, additional, Meier, Megan, additional, Miles, Christopher, additional, Miller, Emily, additional, Miller, Hannah, additional, Mitrani, Raul, additional, Monseau, Aaron J., additional, Moorehead, Benjamin, additional, Myerburg, Robert J., additional, Mytyk, Greg, additional, Narver, Andrew, additional, Nattiv, Aurelia, additional, Nur, Laika, additional, Organ, Brooke E., additional, Pendergast, Meredith, additional, Pettrone, Frank A., additional, Pierce, Jordan, additional, Poddar, Sourav K., additional, Priestman, Diana, additional, Quinn, Ian, additional, Reifsteck, Fred, additional, Restivo, Morgan, additional, Robinson, James B., additional, Roe, Ryan, additional, Rosamond, Thomas, additional, Shearer, Carrie Rubertino, additional, Riveros, Diego, additional, Rueda, Miguel, additional, Sakamoto, Takamasa, additional, Schnebel, Brock, additional, Shah, Ankit B., additional, Shahtaji, Alan, additional, Shannon, Kevin, additional, Sheridan‐Young, Polly, additional, Soslow, Jonathon H., additional, Statuta, Siobhan M., additional, Stovak, Mark, additional, Tarsici, Andrei, additional, Taylor, Kenneth S., additional, Terrell, Kim, additional, Thomason, Matt, additional, Tso, Jason, additional, Vigil, Daniel, additional, Wang, Francis, additional, Winningham, Jennifer, additional, and Zorn, Susanna T., additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results